BioSpace News Archive

The AO Foundation and icotec ag announce the successful agreement and kick-off for the joint development of a new spinal stabilization system based on icotec’s proprietary BlackArmor® Carbon/PEEK composite implant material.

MediWound Ltd. announced that the U.S. Biomedical Advanced Research and Development Authority has expanded its awarded contract with MediWound providing supplemental funding of $5.5 million to support emergency readiness for NexoBrid deployment upon request of use of NexoBrid in mass casualty situation.

Novartis Pharmaceuticals Canada Inc. is pleased to announce that Health Canada has approved MayzentTM for the treatment of adults with secondary progressive multiple sclerosis with active disease evidenced by relapses or imaging features characteristic of multiple sclerosis inflammatory activity, to delay the progression of physical disability.

Building on its 50-year reputation for world-class rehabilitation services, Brooks Rehabilitation continues to elevate patient experience and patient outcomes through a new partnership with interactive patient engagement platform provider SONIFI Health.

MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, announces the publication of “In vitro detection of porphyrin-producing wound bacteria with real-time fluorescence imaging” in Future Microbiology.

Eargo launches free, online hearing check in honor of World Health Organization’s global observance

The Hereditary Neuropathy Foundation Movement is Medicine™ is expanding across the US with its latest Summit announced for March 21, 2020 in Winter Park, Florida at the Center for Health and Wellbeing, which is a collaboration between the Winter Park Health Foundation and AdventHealth.

Aragen Bioscience, Inc, a fully owned subsidiary of GVK BIO and a leading large molecule CRO, and University of Technology Sydney, the top-ranked young university in Australia, are pleased to announce a collaboration to accelerate biologics R&D in Australia.

Aurinia Pharmaceuticals Inc. announced that it will release its fourth quarter and full year 2019 financial results on Thursday, March 5, 2020, after the markets close.

Ra Medical Systems, Inc. (NYSE: RMED) announces that it will report 2019 fourth quarter and full year financial results and provide a business update after market close on Tuesday, March 10, 2020.